Christoph Schlapbach

4.9k total citations · 1 hit paper
66 papers, 3.0k citations indexed

About

Christoph Schlapbach is a scholar working on Dermatology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Christoph Schlapbach has authored 66 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Dermatology, 27 papers in Immunology and 11 papers in Pathology and Forensic Medicine. Recurrent topics in Christoph Schlapbach's work include Dermatology and Skin Diseases (19 papers), Psoriasis: Treatment and Pathogenesis (14 papers) and T-cell and B-cell Immunology (11 papers). Christoph Schlapbach is often cited by papers focused on Dermatology and Skin Diseases (19 papers), Psoriasis: Treatment and Pathogenesis (14 papers) and T-cell and B-cell Immunology (11 papers). Christoph Schlapbach collaborates with scholars based in Switzerland, United States and Germany. Christoph Schlapbach's co-authors include Nikhil Yawalkar, Robert E. Hunger, Rachael A. Clark, Thomas S. Kupper, Jessica E. Teague, Rei Watanabe, Ahmed Gehad, Chao Yang, S. Morteza Seyed Jafari and Victor Huang and has published in prestigious journals such as New England Journal of Medicine, Nature Medicine and Nature Communications.

In The Last Decade

Christoph Schlapbach

60 papers receiving 2.9k citations

Hit Papers

Human skin is protected by four functionally and phenotyp... 2015 2026 2018 2022 2015 100 200 300 400

Peers

Christoph Schlapbach
Katrin Witte Germany
John T. O’Malley United States
Ming-Hong Xie United States
Manjiri Sathe United States
J.‐H. Saurat Switzerland
Katrin Witte Germany
Christoph Schlapbach
Citations per year, relative to Christoph Schlapbach Christoph Schlapbach (= 1×) peers Katrin Witte

Countries citing papers authored by Christoph Schlapbach

Since Specialization
Citations

This map shows the geographic impact of Christoph Schlapbach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christoph Schlapbach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christoph Schlapbach more than expected).

Fields of papers citing papers by Christoph Schlapbach

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christoph Schlapbach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christoph Schlapbach. The network helps show where Christoph Schlapbach may publish in the future.

Co-authorship network of co-authors of Christoph Schlapbach

This figure shows the co-authorship network connecting the top 25 collaborators of Christoph Schlapbach. A scholar is included among the top collaborators of Christoph Schlapbach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christoph Schlapbach. Christoph Schlapbach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jafari, S. Morteza Seyed, et al.. (2025). Topical Ruxolitinib and Delgocitinib Versus Systemic JAK Inhibitors: A Comparative Safety Review. International Journal of Molecular Sciences. 26(21). 10592–10592.
2.
Laursen, Steen, Ida Vittrup, Christoph Schlapbach, et al.. (2025). Preferences in atopic dermatitis: A systematic review. Journal of the European Academy of Dermatology and Venereology. 39(9). 1567–1575.
3.
Heider, Anja, Simone Cazzaniga, Susanne Radonjic‐Hoesli, et al.. (2024). Dupilumab‐associated ocular surface disease is characterized by a shift from Th2/Th17 toward Th1/Th17 inflammation. Allergy. 79(4). 937–948. 15 indexed citations
4.
Maul, Lara Valeska, Alexander Zink, Christoph Schlapbach, et al.. (2024). Predictors of initiating biologics in the treatment of psoriasis. International Journal of Dermatology. 63(10). e231–e239.
5.
Guttman‐Yassky, Emma, Khaled Ezzedine, Christoph Schlapbach, et al.. (2024). Prevalence and clinical impact of topical corticosteroid phobia among patients with chronic hand eczema—Findings from the Danish Skin Cohort. Journal of the American Academy of Dermatology. 91(6). 1094–1103. 4 indexed citations
6.
Bertschi, Nicole, Lisa Taylor, Susanne Radonjic‐Hoesli, et al.. (2023). 105 AhR agonism by tapinarof regulates TH2 and TH17 cell function in human skin. Journal of Investigative Dermatology. 143(11). S350–S350. 1 indexed citations
7.
Bertschi, Nicole, Andrea Felser, Irene Keller, et al.. (2023). PPAR-γ regulates the effector function of human T helper 9 cells by promoting glycolysis. Nature Communications. 14(1). 2471–2471. 26 indexed citations
8.
Roediger, Ben & Christoph Schlapbach. (2022). T cells in the skin: Lymphoma and inflammatory skin disease. Journal of Allergy and Clinical Immunology. 149(4). 1172–1184. 14 indexed citations
9.
Jafari, S. Morteza Seyed, et al.. (2021). Effect of topical application of platelet‐rich plasma on chronic venous leg ulcerations. Dermatologic Therapy. 35(2). e15236–e15236. 3 indexed citations
10.
Jafari, S. Morteza Seyed, et al.. (2021). Case Report: Combination of Omalizumab and Dupilumab for Recalcitrant Bullous Pemphigoid. Frontiers in Immunology. 11. 611549–611549. 40 indexed citations
11.
Hashimoto, Takashi, et al.. (2020). Detection of autoantibodies against alpha-2-macroglobulin-like 1 in paraneoplastic pemphigus sera utilizing novel green fluorescent protein-based immunoassays. Journal of Dermatological Science. 98(3). 173–178. 4 indexed citations
12.
Fässler, Mirjam & Christoph Schlapbach. (2020). Granuloma annulare arising under systemic psoriasis therapy successfully treated with adalimumab. JAAD Case Reports. 6(9). 832–834. 12 indexed citations
13.
Kromer, Christian, Mario Fabri, Christoph Schlapbach, et al.. (2019). Diagnosis of mycobacterial skin infections. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 17(9). 889–893. 7 indexed citations
14.
Adam, Christian, Cédric Simillion, S. Morteza Seyed Jafari, et al.. (2019). Human “T H 9” cells are a subpopulation of PPAR-γ + T H 2 cells. Science Immunology. 4(31). 93 indexed citations
15.
Bertschi, Nicole, et al.. (2019). Targeting T Cell Metabolism in Inflammatory Skin Disease. Frontiers in Immunology. 10. 2285–2285. 22 indexed citations
16.
Schlapbach, Christoph, et al.. (2018). Multiple acantholytic dyskeratotic acanthomas in an organ transplant recipient. JAAD Case Reports. 4(7). 695–697. 3 indexed citations
17.
Schlapbach, Christoph & Parham Sendi. (2017). Serrated Marine Nose. New England Journal of Medicine. 376(3). 267–267.
18.
Schlapbach, Christoph, Ahmed Gehad, Chao Yang, et al.. (2014). Human T H 9 Cells Are Skin-Tropic and Have Autocrine and Paracrine Proinflammatory Capacity. Science Translational Medicine. 6(219). 219ra8–219ra8. 163 indexed citations
19.
Purwar, Rahul, Christoph Schlapbach, Sheng Xiao, et al.. (2012). Robust tumor immunity to melanoma mediated by interleukin-9–producing T cells. Nature Medicine. 18(8). 1248–1253. 319 indexed citations
20.
Schlapbach, Christoph, et al.. (2011). Telomerase-specific GV1001 peptide vaccination fails to induce objective tumor response in patients with cutaneous T cell lymphoma. Journal of Dermatological Science. 62(2). 75–83. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026